Nearly four months after the FDA said it was investigating reports of China-made syringes breaking and leaking, the agency confirmed the quality issue and found the problem is “more widespread than originally known.”
The American Hospital Association’s supply chain group, Association for Health Care Resource & Materials Management, named Mike Schiller as its new executive director March 18.
A software company that went through Los Angeles-based Cedars-Sinai’s accelerator program is aiming to streamline the medical device recall process, Fast Company reported March 14.
For about a year, Cleveland Clinic has built and tested an AI-powered chatbot that generates answers on supply orders. Over the next three months, the technology will be launched to the system’s 7,000-some employees who regularly place orders.
Cardinal Health revised its product correction for more than 27 million syringes, upgrading the notice to a Class I recall — the most serious type — on Feb. 2.
The largest health system in Maryland is constructing a logistics operations center to centralize its medical supply storage, The Baltimore Banner reported March 8.
Medtronic Neurosurgery is recalling 45,176 drainage systems because catheters might disconnect from patient line stopcock connectors. There have been 26 reported injuries, the FDA said March 7.
More than four dozen health systems have pledged to adopt the Healthcare Industry Resilience Collaborative’s resiliency badge, which seeks to improve trust between medical suppliers and providers.